158 related articles for article (PubMed ID: 34946244)
1. The Concentration of CMKLR1 Expression on Clinicopathological Parameters of Colorectal Cancer: A Preliminary Study.
Kiczmer P; Mielcarska S; Chrabańska M; Dawidowicz M; Kula A; Rynkiewicz M; Seńkowska AP; Waniczek D; Piecuch J; Jopek J; Kajor M; Świętochowska E
Medicina (Kaunas); 2021 Nov; 57(12):. PubMed ID: 34946244
[No Abstract] [Full Text] [Related]
2. Assessment of CMKLR1 level in colorectal cancer and its correlation with angiogenic markers.
Kiczmer P; Seńkowska AP; Kula A; Dawidowicz M; Strzelczyk JK; Zajdel EN; Walkiewicz K; Waniczek D; Ostrowska Z; Świętochowska E
Exp Mol Pathol; 2020 Apr; 113():104377. PubMed ID: 31926977
[TBL] [Abstract][Full Text] [Related]
3. GDF-15 Level Correlates with CMKLR1 and VEGF-A in Tumor-free Margin in Colorectal Cancer.
Mielcarska S; Stopińska K; Dawidowicz M; Kula A; Kiczmer P; Seńkowska AP; Zajdel EN; Walkiewicz K; Waniczek D; Świętochowska E
Curr Med Sci; 2021 Jun; 41(3):522-528. PubMed ID: 34169422
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the RANTES Level Correlation and Selected Inflammatory and Pro-Angiogenic Molecules Evaluation of Their Influence on CRC Clinical Features: A Preliminary Observational Study.
Mielcarska S; Kula A; Dawidowicz M; Kiczmer P; Chrabańska M; Rynkiewicz M; Wziątek-Kuczmik D; Świętochowska E; Waniczek D
Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208526
[No Abstract] [Full Text] [Related]
5. Periostin in Angiogenesis and Inflammation in CRC-A Preliminary Observational Study.
Kula A; Dawidowicz M; Mielcarska S; Kiczmer P; Chrabańska M; Rynkiewicz M; Świętochowska E; Waniczek D
Medicina (Kaunas); 2022 Jan; 58(1):. PubMed ID: 35056404
[No Abstract] [Full Text] [Related]
6. Chemerin and Chemokine-like Receptor 1 Are Not Prognostic in Colorectal Carcinoma.
Weber F; Jung R; Treeck O; Buechler C
Anticancer Res; 2023 Feb; 43(2):831-839. PubMed ID: 36697076
[TBL] [Abstract][Full Text] [Related]
7. Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties.
Yoshimura T; Oppenheim JJ
Exp Cell Res; 2011 Mar; 317(5):674-84. PubMed ID: 21056554
[TBL] [Abstract][Full Text] [Related]
8. Involvement of cyclooxygenase-2 and vascular endothelial growth factor in vascularization and lymph node metastasis of colorectal cancers with submucosal invasion.
Abe A; Fukui H; Fujii S; Fujita M; Mukawa K; Ichikawa K; Tomita S; Ono Y; Imai Y; Imura J; Kubota K; Fujimori T
J Gastroenterol Hepatol; 2007 Jul; 22(7):1071-7. PubMed ID: 17608853
[TBL] [Abstract][Full Text] [Related]
9. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
[TBL] [Abstract][Full Text] [Related]
10. Correlational research of Golgi phosphorylation protein 3 expression in colorectal cancer.
Guo YT; Qiu CZ; Huang ZX; Yu WS; Yang XF; Wang MZ
World J Gastroenterol; 2015 Dec; 21(48):13473-9. PubMed ID: 26730158
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the correlation of vasculogenic mimicry, ALDH1, KAI1 and microvessel density in the prediction of metastasis and prognosis in colorectal carcinoma.
Zhu B; Zhou L; Yu L; Wu S; Song W; Gong X; Wang D
BMC Surg; 2017 Apr; 17(1):47. PubMed ID: 28431527
[TBL] [Abstract][Full Text] [Related]
12. Hepatic chemerin and chemokine-like receptor 1 expression in patients with chronic hepatitis C.
Kukla M; Adamek B; Waluga M; Zalewska-Ziob M; Kasperczyk J; Gabriel A; Mazur W; Sobala-Szczygieł B; Bułdak RJ; Zajęcki W; Kępa L; Ziora K; Żwirska-Korczala K; Wiczkowski A; Hartleb M
Biomed Res Int; 2014; 2014():517820. PubMed ID: 25121101
[TBL] [Abstract][Full Text] [Related]
13. Budding and tumor-infiltrating lymphocytes - combination of both parameters predicts survival in colorectal cancer and leads to new prognostic subgroups.
Lang-Schwarz C; Melcher B; Haumaier F; Lang-Schwarz K; Rupprecht T; Vieth M; Sterlacci W
Hum Pathol; 2018 Sep; 79():160-167. PubMed ID: 29787819
[TBL] [Abstract][Full Text] [Related]
14. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5.
Sadek SA; A Rehim DM; Fatima S
Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119
[TBL] [Abstract][Full Text] [Related]
15. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
Ding C; Li L; Yang T; Fan X; Wu G
BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
17. Expression of Duffy antigen receptor for chemokines (DARC) is down-regulated in colorectal cancer.
Zhou S; Liu M; Hu Y; An W; Liang X; Yu W; Piao F
J Recept Signal Transduct Res; 2015; 35(5):462-7. PubMed ID: 26096170
[TBL] [Abstract][Full Text] [Related]
18. Role of chemerin/CMKLR1 in the maintenance of early pregnancy.
Yang X; Yao J; Wei Q; Ye J; Yin X; Quan X; Lan Y; Xing H
Front Med; 2018 Oct; 12(5):525-532. PubMed ID: 29556954
[TBL] [Abstract][Full Text] [Related]
19. Predictive values of FAP and HGF for tumor angiogenesis and metastasis in colorectal cancer.
Ma TH; Gao CC; Xie R; Yang XZ; Dai WJ; Zhang JL; Yan W; Wu SN
Neoplasma; 2017; 64(6):880-886. PubMed ID: 28895412
[TBL] [Abstract][Full Text] [Related]
20. Chemerin Elicits Potent Constrictor Actions via Chemokine-Like Receptor 1 (CMKLR1), not G-Protein-Coupled Receptor 1 (GPR1), in Human and Rat Vasculature.
Kennedy AJ; Yang P; Read C; Kuc RE; Yang L; Taylor EJ; Taylor CW; Maguire JJ; Davenport AP
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27742615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
